ST. PETERSBURG, FL, Oct. 2, 2014 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTCQB: FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announces major traction of its recently launched affordable PersonalAnalytics Cannabis THC & CBD test kits. PersonalAnalytics test kits are the world's first ever affordable home testing kits for potency of cannabis cannabinoids (THC & CBD). The tests are sold through CB Scientific, a wholly owned subsidiary of FutureWorld Corp.
"PersonalAnalytics THC & CBD" were launched only 3 weeks ago at the HIGH TIMES Cannabis Cup in Everett WA and have already sold several thousand test kits with thousands more on backorder. We estimate "PersonalAnalytics" could become one of the biggest revenue drivers in the near future for FWDG and its subsidiary, CB Scientific. Currently the company is in the process of developing major distribution channels throughout the United States and Europe, with plans to attend the HIGH TIMES Cannabis Cup in Amsterdam late November.
Now, anyone anywhere in the world can affordably have a quick and accurate test to see the relative potency levels of their cannabis medicine. FWDG is putting power in the hands of patients worldwide who need to use medical cannabis and hemp-related products such as CBD oil. In Colorado, California and Washington, caregivers are now able to get affordable and high-quality test results in 10 minutes or less. Patients in any other state or country also now have the opportunity to know what is in their medicine and its potency level without the high costs of an outside laboratory.
PersonalAnalytics THC & CBD: Simple, Easy, Accurate, and Affordable!
Mitch Shenassa, inventor of the IncrediBowl and winner of 18 HIGH TIMES Cannabis Cups, called our product "the coolest thing I've seen in Cannabis since my product." Adam Dunn, host of The Adam Dunn Show on icannabisradio.com called "PersonalAnalytics" his official vote for Best Product for the next several cups.
With groups such as the CannaMoms of St Petersburg FL needing help with their son's and daughter's cannabis treatments, CB Scientific is making a donation of several test kits to help alleviate their concern about safety and potency of the medicines. If anyone deserves to truly know what is in their medicine before it is consumed it is our children!
Both THC and CBD home testing kits are already available at several outlets in Spokane, Washington and Denver, Colorado, including head shops, dispensaries and grow stores. The kits are also available for purchase worldwide online at cbscientific.com.
About CB Scientific
CB Scientific (http://www.cbscientific.com) is a wholly owned Florida company based in Denver Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis analytics. Senior management team includes Charlie Steinberg and Derek Lebahn. Mr. Steinburg and Mr. Lebahn are some of the primary men advancing gas chromatography testing in Colorado. Mr. Steinburg has also pioneered residual solvent testing for medical cannabis and has always strived to help patients know exactly what they are buying. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution.
Senior management team of CB Scientific have worked with many of the cannabis industry leaders in Colorado and have also been featured in cannabis industry publications including High Times Magazine, many trade publications, on-air interviews and panel discussions across the United States. CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.
About FutureWorld Corp
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company, listed on the Over the Counter exchange, which was formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. HempTech, a subsidiary of FutureWorld, is a technology division catered to the cannabis and the industrial Hemp market. HempTech provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal marijuana. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global Hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.
To request further information about FutureWorld, please email us at investors@futureworldcorp.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page https://www.facebook.com/futureworldenergy.
Forward-Looking Statements
This press release may contain forward-looking statements covered
within the meaning of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements relate to, among other
things, plans and timing for the introduction or enhancement of our
services and products, statements about future market conditions,
supply and demand conditions, and other expectations, intentions
and plans contained in this press release that are not historical
fact and involve risks and uncertainties. Our expectations
regarding future revenues depend upon our ability to develop and
supply products and services that we may not produce today and that
meet defined specifications. When used in this press release, the
words "plan," "expect," "believe," and similar expressions
generally identify forward-looking statements. These statements
reflect our current expectations. They are subject to a number of
risks and uncertainties, including, but not limited to, changes in
technology and changes in pervasive markets. This release includes
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 27E of the Securities Act of
1934. Statements contained in this release that are not historical
facts may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain.
Actual performance and results may differ materially from that
projected or suggested herein due to certain risks and
uncertainties including, without limitation, ability to obtain
financing and regulatory and shareholder approval for anticipated
actions.